Back
Ultragenyx Pharmaceutical Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
13
RARE
Ultragenyx Pharmaceutical
Last Price:
$41.49
Seasonality Move:
3.93%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Caught Trading Under Secret Name...
Find out more about the "hidden stock" here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.73 | Sell |
| 20-day SMA: | 44.98 | Sell |
| 50-day SMA: | 47.54 | Sell |
| 200-day SMA: | 47.61 | Sell |
| 8-day EMA: | 42.58 | Sell |
| 20-day EMA: | 44.29 | Sell |
| 50-day EMA: | 47.02 | Sell |
| 200-day EMA: | 47.92 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.75 | Sell |
| Relative Strength Index (14 RSI): | 29.19 | Sell |
| Chaikin Money Flow: | -78040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.93 - 48.01) | Sell |
| Bollinger Bands (100): | (46.62 - 56.6) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 41.50 while RARE 8-day simple moving average is 42.73, which is a Sell signal.
-
The stock price of RARE is 41.50 while Ultragenyx Pharmaceutical 20-day SMA is 44.98, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 47.54 while RARE share price is 41.50, making it a Sell technically.
-
RARE stock price is 41.50 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.61, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
13
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $41.50. The Score for RARE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.8B
Price in USD:
41.50
Share Volume:
1.5M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
37.02
Sell
13
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 41.50 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 41.50 while RARE 8-day exponential moving average is 42.58, which is a Sell signal.
-
The stock price of RARE is 41.50 while Ultragenyx Pharmaceutical 20-day EMA is 44.29, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 47.02 while RARE share price is 41.50, making it a Sell technically.
-
RARE stock price is 41.50 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.92, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $1.51 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -1.75, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 29.19, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (42.93 - 48.01), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (46.62 - 56.6), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.